APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B
Clinical trial NCT03585322 · COMPLETED
Trial details
- NCT number
- NCT03585322
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-04
- Primary completion
- 2021-10-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.